Michael has 25 years of commercial, research and teaching experience in the life sciences, including ten years in the diagnostics and biotech sectors in the UK. He has lived on four continents and worked across five over this time.
Michael has held senior management, advisory and technical consultancy roles within corporate and SME organisations in the UK, USA, South Africa, South America and Asia, serving diverse client bases ranging from privately owned to government and intergovernmental bodies.
He has created, led, supported or turned-around blue biotech organisations, API Manufacturers, Medical Device companies and a drug development organisation. These organisations have ranged from pre-revenue to companies with annual revenues of over USD20 million. He has raised USD15 million in pre-Series A investment and over USD1.5 million in undiluted grant funding. Beyond that, Michael has taught microanatomy and microbiology in Higher Education and has supervised and co-supervised Masters and Doctoral level candidates on three continents.
Michael has PhDs in Anatomy and in Pharmaceutical Chemistry, is a co-author on various drug development publications and holds joint inventorship on seven patents in microbial control and diagnostics.
Heather has an MBA from the University of Exeter and before that, 25 years of experience in business management and providing direct patient care. She transitioned from neurorehabilitation into the biotechnology sector in 2014 and has been responsible for managing commercial and business development aspects of biotechnology companies since then.
Heather has a particular interest in developing sustainable business models for providing effective healthcare and for developing and commercialising new and effective antimicrobials. She is also passionate about giving companies a voice to tell their stories.
Stewart has over 10 years of experience as a Quality Manager in the Food, Biotechnology and Pharmaceutical industries and has worked in South Africa, the USA and currently in the UK. His keen eye for detail and pragmatic approach to understanding and solving problems meant he was recognised as a Quality Risk Management expert for a large, multinational sterile parenteral pharmaceutical company where he was also key in managing their audit readiness strategy.
Stewart has lead R&D teams in biotechnology and medical device development projects and has a keen understanding of the Regulatory environment relating to GxP.
Stewart has a Masters in Biotechnology from Rhodes University in South Africa and a PhD in Microbiology from the Center for Biofilm Engineering at Montana State University in the USA.
Dr Bryan Hanley
Bryan is a biological chemist and has worked extensively in the agri-food and biotechnology sectors. He has worked for publically funded research institutes, the EU and commercial organisations in the UK, Europe and the US. His industrial experience includes the FMCG and pharmaceuticals sectors, SMEs, membership and not-for-profit organisations.
Bryan has held senior management and Board positions and has initiated and led work in a number of areas including the development and use of biomarkers, novel aspects of enzyme catalysed reactions, natural product chemistry and nutrition. He has also worked with Learned Societies and held posts of President (Royal Society of Chemistry, Industry and Technology Division) and Chairman (Royal Society of Chemistry, Food Group) as well as a number of committee and advisory positions. He is a Chartered Chemist and Fellow of the Royal Society of Chemistry, the Royal Society of Biology and the International Union of Pure and Applied Chemistry (IUPAC).
He has published over 70 articles in peer reviewed journals and is joint inventor on a number of patents. He has also co-supervised PhD students and has delivered lectures to technical and non-technical audiences on a number of topics.